John A. Lewicki, Chief Scientific Officer at Mereo BioPharma Group plc (MREO), sold 16,149 shares at $4.22 ($69K) on 2024-09-13, disclosed to the SEC on 2024-09-16.
Open-market sale of $69k MREO by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.47 | 5,212 | $23K | 33.5% |
| 2 | $4.22 | 10,937 | $46K | 66.5% |
| Total | $4.30 avg | 16,149 | $69K | 100% |
| Filing → |
| OMED | SELL | 2018-10-10 | $5K | — | Filing → |
| OMED | SELL | 2018-04-26 | $12K | — | Filing → |
| OMED | SELL | 2017-10-12 | $5K | — | Filing → |